Medicine and Dentistry
Childbirth
100%
Cohort Analysis
94%
Gestational Age
69%
Newborn Morbidity
60%
Severe Acute Respiratory Syndrome Coronavirus 2
60%
Umbilical Cord
60%
Infection
43%
Hazard Ratio
43%
Cesarean Section
43%
Newborn Mortality
39%
Premature Labor
38%
Adverse Outcome
36%
Intrapartum
36%
Uterine Rupture
30%
Disease Severity
30%
Tissue Doppler Imaging
30%
Coronary Angiography
30%
Diabetes Mellitus
30%
Cardiotocography
30%
Newborn Care
30%
Heart Left Ventricle Ejection Fraction
30%
Case-Control Study
30%
Case Mix
20%
Heart Failure
20%
Newborn Death
14%
Medical Record
13%
Small for Gestational Age
12%
Proportional Hazards Model
12%
COVID-19
12%
Odds Ratio
12%
Artificial Respiration
12%
Trial of Labor
11%
Asthma
10%
Surfactant
9%
High Risk Population
9%
Birth Rate
9%
Coronary Artery
9%
Antenatal Corticosteroid
9%
Valvular Heart Disease
9%
Adverse Event
9%
Ischemic Heart Disease
9%
Diabetes
9%
Systolic Dysfunction
9%
Atrial Fibrillation
9%
Echocardiography
9%
Perinatal Care
9%
Observational Study
9%
Heart Death
9%
Bundle Branch Block
9%
pH Measurement
8%
Keyphrases
Infection In Pregnancy
30%
Prior Cesarean Delivery
30%
SARS-CoV-2 Diagnosis
30%
Between-hospital Variation
30%
Intrapartum Cardiotocography
30%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
30%
Prospective Cohort Study
30%
Cardiotocograph
30%
Uterine Rupture
30%
Odds Ratio
26%
COVID-19
22%
Fetal Hypoxia
20%
Risk Factors
18%
Spontaneous Uterine Rupture
18%
Hospital Admission
15%
Breech Presentation
15%
Gestational Age
15%
Trial of Labor
12%
Universal Measurements
11%
Asthma
11%
Measuring Quality
9%
Hospital Birth
9%
Postpartum Hemorrhage
9%
Infant Exposure
9%
Perinatal Management
9%
Perinatal Intervention
9%
Neonatal Management
9%
Coronary Artery Pathology
9%
Severe Infection
7%
Identify Risk
7%
Hypothermia Treatment
7%
Umbilical Cord Blood Gas Analysis
7%
Obesity
7%
During Pregnancy
7%
Neonatal Outcome
7%
Fetal Tachycardia
6%
TOLAC
6%
Group-level Outcome
6%
First Stage of Labor
6%
Variable Decelerations
6%
Uterine Tachysystole
6%
Elective CS
5%
Cephalopelvic Disproportion
5%